ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2013 ACR/ARHP Annual Meeting

October 25-30, 2013. San Diego, CA.

View by Title View Sessions
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Abstract Number: 1069
    Racial Differences In Systemic Lupus Erythematosus Patients’ Treatment Preferences: A Two-Site Study
  • Abstract Number: 1996
    Racial/Ethnicity Differences In Health-Related Quality Of Life (HRQOL), Functional Ability and Health Care Utilization In Gout Patients
  • Abstract Number: 2469
    Radiographic Sacroiliitis Progression In An Early Spondyloarthritis Cohort
  • Abstract Number: 2804
    Radiological Outcome Of Joints With MRI Detected Subclinical Inflammation In Early Arthritis Patients
  • Abstract Number: 143
    Rapid Infrared Microscopy (IRMS) For Differential Diagnosis Of Fibromyalgia and Other Central Sensitivity Syndromes
  • Abstract Number: 2535
    Rare Autoantibodies To Cellular Antigens In Systemic Lupus Erythematosous
  • Abstract Number: 745
    Rate Of Infection and Development Of Malignancy In Patients With ANCA-Associated Vasculitis Treated With Rituximab: A Meta-Analysis From Randomized Trials
  • Abstract Number: 282
    Rates Of Flare-Free Survival In Juvenile Idiopathic Arthritis When Tapering Individual Components Of Tumor Necrosis Factor Inhibitor and Methotrexate Combination Therapy
  • Abstract Number: 1047
    Rates Of Hospitalized Infections In Rheumatoid Arthritis Patients From 5 Rheumatoid Arthritis Registries Across The World
  • Abstract Number: 782
    Rates Of Malignancies In Patients From 5 Rheumatoid Arthritis Registries Across The World
  • Abstract Number: 1458
    Rates Of Switching and Healthcare Costs Associated With Switching Biologic Disease-Modifying Antirheumatic Drugs In a Commercial Population: Evidence From Real-World Observational Studies
  • Abstract Number: 504
    Raynaud’s Phenomenon and African American Race Are Independently Associated With Non-Hodgkin’s Lymphoma In Sjogrens Syndrome Patients: Findings From a United States National Study
  • Abstract Number: 1791
    Reaching The Target Of Low Disease Activity At 6 Months Predicts Better Long-Term Functional Outcome In Patients With Early Rheumatoid Arthritis
  • Abstract Number: 1030
    Readability of Participant Information and Consent Forms for Rheumatology Clinical Trial Participants
  • Abstract Number: 1718
    Reading Of The Sacroiliac Joints On Plain Radiographs: Agreement Between Clinical Practice and Trained Central Reading Of The DESIR-Cohort
  • Abstract Number: 2852
    Real-Life Assessment Of The Validity Of Patient Global Impression Of Change In Fibromyalgia
  • Abstract Number: 473
    Real-World Effectiveness and Safety Of Infliximab In The Treatment Of Rheumatoid Arthritis Over 5 Years: The Canadian Experience
  • Abstract Number: 1554
    Real-World Effectiveness Of Infliximab In The Treatment Of Psoriatic Arthritis Over 12 Months: The Canadian Experience
  • Abstract Number: 1468
    Reasons For Discontinuation Of Biologic Agents In Rheumatoid Arthritis Patients
  • Abstract Number: 849
    Reasons For Failure To Obtain Influenza and Pneumococcal Vaccines Among Immunosuppressed Individuals With Systemic Lupus Erythematosus
  • Abstract Number: 794
    Recent Trends In Medication Usage for the Treatment of Juvenile Idiopathic Arthritis and the Influence of TNF Inhibitors
  • Abstract Number: 2647
    Recombinant Monoclonal Antibodies Derived From Single CD19+ Synovial B Cells Of RA Patients With Tertiary Lymphoid Structures Display a Strong Immunoreactivity Towards Citrullinated Histones
  • Abstract Number: 2579
    Recommendations For Screening and Detection Of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension
  • Abstract Number: 838
    Recommendations for the Classification and Diagnosis of Fibromyalgia Syndrome Provided By Independently Developed Evidence-Based Interdisciplinary Guidelines Spanning Three Continents
  • Abstract Number: 2127
    Recurrences Of Hallux Valgus Deformity After Implant Surgery For Greater Toe In Rheumatoid Arthritis
  • Abstract Number: 2751
    Recurrent Pericarditis In Children and Adolescents: Etiology, Presentation, Therapies, and Outcomes In a Multicenter Retrospective Cohort Of 100 Patients
  • Abstract Number: 964
    Redesign Of a Rheumatology Curriculum For Internal Medicine Residents: Results Of Needs Assessment Survey
  • Abstract Number: 923
    Redox Dependent Conformational Changes Of The Autoantigen La Are Responsible For Its Shuttling, Translocation and a Pathophysiological Role Of Anti-La Autoantibodies
  • Abstract Number: 2398
    Redox Mediated Angiogenesis In The Hypoxic Joint Of Inflammatory Arthritis
  • Abstract Number: 2681
    Reduced Fertility In Women With Rheumatoid Arthritis: Influence Of Disease Activity and Medication Use
  • Abstract Number: 2602
    Reduced Frequencies Of Circulating CD8 T Cells In Early Diffuse Cutaneous Systemic Sclerosis Is Associated With Worse Skin Scores
  • Abstract Number: 867
    Reduced Hip Cortical Porosity Upon Denosumab Treatment: A Likely Mechanism Contributing To The Reduction Of Hip Fracture Risk In Women With Osteoporosis
  • Abstract Number: 1401
    Reduced Oral Glucose Tolerance Is Associated With a Lower Risk Of Rheumatoid Arthritis
  • Abstract Number: 633
    Reduced PD-1 Signaling Promotes Suppressive Function Of CD4+ Regulatory T Cells In Patients With Systemic Lupus Erythematosus
  • Abstract Number: 462
    Reduced Response To Biologic Treatments in  Rheumatoid Arthritis Patients Affected By Arterial Hypertension
  • Abstract Number: 2315
    Reducing The Need For Total Knee Arthroplasty:  The Experience Of a Multidisciplinary Osteoarthritis Clinic
  • Abstract Number: 939
    Reduction Of Circulating Blood Neutrophils In Mice By Anti-IL-6R Alpha Monoclonal Antibody is Not Due To Apoptosis Or Blockade Of Neutrophil Differentiation
  • Abstract Number: 1520
    Reduction Of Disease Burden On Workplace and Household Productivity In Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis, Over 48 Weeks Of Treatment With Certolizumab Pegol
  • Abstract Number: 326
    Reduction Of Disease Burden On Workplace and Household Productivity In Psoriatic Arthritis Over 48 Weeks Of Treatment With Certolizumab Pegol
  • Abstract Number: 1057
    Regional Variations In Rheumatoid Arthritis Treatment and Health Outcomes Across The United States
  • Abstract Number: 1542
    Regular Exercise Is Associated With Better Functional Outcomes In Ankylosing Spondylitis
  • Abstract Number: 2725
    Regulation Of Aberrant CD4 T Cell Activation By Suppressor Of Cytokine Signaling-1 (SOCS1) Mimetic Peptide, Has Relevance To Human Systemic Lupus Erythematosus
  • Abstract Number: 1145
    Regulation Of Plasmacytoid Dendritic Cells By Prostaglandin E2
  • Abstract Number: 918
    Regulatory B Cells Suppress Skin Inflammation in a Murine Model of Psoriasis
  • Abstract Number: 1402
    Regulatory B10 Cells Are Decreased In Patients With Rheumatoid Arthritis and Inversely Correlated With Disease Activity
  • Abstract Number: 132
    Relation Of Age With Symptom Severity and Quality Of Life In Patients With Fibromyalgia
  • Abstract Number: 615
    Relationship Between 25-Hydroxyvitamin D [25(OH)D] and Risk For Cardiovascular Events In Systemic Lupus Erythematosus Over 11 Years In An Inception Cohort
  • Abstract Number: 2838
    Relationship Between Active Inflammatory Lesions In The Spine and Sacroiliac Joints and Development Of Fatty Lesions On Whole-Body MRI In Patients With Early Axial Spondyloarthritis-  Long-Term Data Of The Esther Trial
  • Abstract Number: 1100
    Relationship Between Body Mass Index, Fat Mass and Muscle Mass Withmusculoskeletal Pain In Community Residents
  • Abstract Number: 2475
    Relationship Between Extra-Articular Manifestations and Disease Activity In Patients Diagnosed With New-Onset Spondyloarthropathy In a Cohort In Spain
  • Abstract Number: 744
    Relationship Between Infectious Side Effects and Immunoglobulin Levels In The Maintenance Rituximab Vs Azathioprine For ANCA-Associated Vasculitides Trial
  • Abstract Number: 2330
    Relationship Between Lymphocyte Count and Risk Of Infection In Rheumatoid Arthritis Patients Treated With Tofacitinib
  • Abstract Number: 1801
    Relationship Between MRI and Clinical Remission In Patients With Non-Radiographic Axial Spondyloarthritis After Two Years Of Adalimumab Therapy
  • Abstract Number: 1479
    Relationship Between physicians’ Decision To Use Concomitant Glucocorticoid and Remission During Treatment With Tocilizumab In Patients With Background Of Limited Dose Of MTX
  • Abstract Number: 1950
    Relationship Between Radiographic Joint Space Narrowing, Sonographic Cartilage Thickness and Anatomy In Rheumatoid Arthritis and Control Joints
  • Abstract Number: 215
    Relationship Between Structural Joint Damage and Urate Deposition In Gout: A Site-By-Site Analysis Using Plain Radiography and Dual Energy Computed Tomography
  • Abstract Number: 778
    Relationship of Meeting Physical Activity Guidelines and Quality Adjusted Life Years
  • Abstract Number: 2753
    Relationship Of Pre-Radiographic MRI Lesions With Prevalent Frequent Knee Symptoms and Incident Persistent Knee Symptoms In Persons At Higher Risk For Knee Osteoarthritis
  • Abstract Number: 831
    Relationships Between Clinical Outcome Measures and Gait Variables Before and After Total Hip Arthroplasty
  • Abstract Number: 1760
    Relationships Between Driving Distance, Rheumatoid Arthritis Diagnosis, and Disease-Modifying Anti-Rheumatic Drug Receipt
  • Abstract Number: 2176
    Relationships Between Physician and Patient Scored Clinical Outcome Measures In Pediatric Localized Scleroderma
  • Abstract Number: 2103
    Relationships Between Self-Efficacy, Outcome Expectancy, and Outcomes In Older Adults With Osteoarthritis Of The Knee and Hypertension: Baseline Results
  • Abstract Number: 2788
    Reliability and Responsivenss Of The Standardized Universal Pain Evaluations For Rheumatology Providers For Children and Youth (SUPER-KIDZ)
  • Abstract Number: 2286
    Reliability and Smallest Detectable Difference Of The Patient Global Assessment, Pain and Fatigue In Rheumatoid Arthritis Patients
  • Abstract Number: 2868
    Reliability and Validity Of Patient-Reported Joint Counts and Determinants Of Disagreement With The Physician In Recent Onset Rheumatoid Arthritis
  • Abstract Number: 801
    Remaining Pain Is Common In Early RA Patients Treated With Methotrexate – Results From The EIRA Cohort and The Swedish Rheumatology Quality Register
  • Abstract Number: 1353
    Remission After Twelve Month Of Treatment In The Prague Early Rheumatoid Arhritis Cohort
  • Abstract Number: 1977
    Remission At 3 Or 6 Months and Radiographic Non-Progression At 12 Months In Methotrexate-Naïve Rheumatoid Arthritis Patients Treated With Tofacitinib Or Methotrexate: A Post-Hoc Analysis Of The ORAL Start Trial
  • Abstract Number: 1522
    Remission In Spondyloarthritis :  ASDAS and Basdai Thresholds From a Prospective Real Life Study
  • Abstract Number: 446
    Remission Rates During Golimumab Treatment For Rheumatoid Arthritis Are Associated With Differences In Baseline Disease States Across Geographic Regions
  • Abstract Number: 594
    Renal Biopsy Findings In Lupus Patient With Insignificant Proteinuria : Relation To Disease Activity and Clinical Manifestations
  • Abstract Number: 602
    Repeat Biopsy In Lupus Nephritis: A Single-Center Experience
  • Abstract Number: 1453
    Repeated High Or Low Multi-Biomarker Disease Activity (VECTRA® DA Algorithm) Scores Associated With Radiographic Outcomes In Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors
  • Abstract Number: 274
    Reported Macrophage Activation Syndrome In Patients With Systemic-Onset Juvenile Idiopathic Arthritis Treated With Tocilizumab
  • Abstract Number: 1898
    Repression Of Wolf-Hischhorn Syndrome Candidate-1 (WHSC1) Contributes To The Osteoarthritis-Inducing Cartilage Loss Of Functions
  • Abstract Number: 989
    Reproductive Counseling Program For Lupus Patients At The Systemic Lupus Erythematosus-Antiphospholipid Syndrome Center Of Excellence At Hospital For Special Surgery
  • Abstract Number: 2266
    Research On Factors Influenced For Bone Metabolic Markers In Rheumatoid Arthritis Patients From Prospective Cohort Study
  • Abstract Number: 6
    Researchers’ Own Experience In Managing Obstetric Complications In Pregnant Women With Antiphospholipid Syndrome
  • Abstract Number: 2745
    Reshaping Inflammatory Macrophage Development and Functions by a Monosaccharide Analogue In Rheumatoid Arthritis
  • Abstract Number: 1214
    Resistant Or Recurrent Acute Pericarditis: A New Therapeutic Opportunity?
  • Abstract Number: 521
    Respiratory Compromise In Patients With Primary Sjögren Syndrome
  • Abstract Number: 2405
    Respiratory Diseases As Risk Factors For Rheumatoid Arthritis
  • Abstract Number: 878
    Responders To Tocilizumab Identified By Serological Measurement Of Connective Tissue Type I Collagen In Patients With Rheumatoid Arthritis
  • Abstract Number: 2247
    Response To a Sleep Query On The Multi-Dimensional Health Assessment Questionnaire (MDHAQ) Is Related To Levels Of Disease Activity
  • Abstract Number: 484
    Response To Biologic Disease-Modifying Anti-Rheumatic Drugs After Discontinuation Of Anti-Tumor Necrosis Factor Alpha  Agents In Rheumatoid Arthritis Patients
  • Abstract Number: 355
    Response To Etanercept With Or Without Methotrexate Combination Therapy In Patients With Psoriatic Arthritis
  • Abstract Number: 1141
    Response To H. Pylori Treatment and Autoantibody In Chronic Thrombocytopenia
  • Abstract Number: 2467
    Response to Tumor Necrosis Factor inhibitors In Axial Spondyloarthritis: Does Sacroiliitis Make Any Difference?
  • Abstract Number: 2134
    Responsiveness and Predictive Ability Of The Knee Society Scale (KSS) Score
  • Abstract Number: 1553
    Responsiveness Of Health Related Quality Of Life Questionnaires To Treatment With Anti-TNF Therapy In Psoriatic Arthritis
  • Abstract Number: 2275
    Responsiveness Of The Outcomes Measures In Rheumatology Clinical Trials Initiative’s Preliminary Flare Questions To Detect Flares Within Patients In The Canadian Early Arthritis Cohort
  • Abstract Number: 306
    Responsiveness To Change Of a Global Ultrasound Assessment Score In Psoriatic Arthritis Patients
  • Abstract Number: 2854
    Restricting Back Pain and Subsequent Mobility Disability In Community-Living Older Persons
  • Abstract Number: 877
    Results From The RATE-RA Study: A Multicenter, Single-Arm Study To Evaluate The Safety Of Administering Rituximab At a More Rapid Infusion Rate In Patients With Rheumatoid Arthritis
  • Abstract Number: 434
    Results Of 64 Weeks Of Treatment With An Anti-IL-17 Antibody, Ixekizumab, In Patients With Rheumatoid Arthritis In a Phase 2 Study
  • Abstract Number: 278
    Results Of a 24 Month Extension Study In Patients Who Participated In The Trial Of Early Aggressive Therapy In Polyarticular Juvenile Idiopathic Arthritis
  • Abstract Number: 814
    Results Of a Randomised Controlled Trial Comparing Tight Control Of Early Psoriatic Arthritis (TICOPA) With Standard Care: Tight Control Improves Outcome
  • Abstract Number: 1943
    Results of a Reliability Exercise for the Grading of Tendon Rupture in Patients With Rheumatoid Arthritis, using  a Consensus-Based Ultrasound Score
  • Abstract Number: 2691
    Results Of The Strass Trial Regarding Impact Of Progressive Spacing Of Tnf-Blocker Injections In Rheumatoid Arthritis Patients In Das28 Remission: Is There a Difference Between Drugs – Adalimumab and Etanercept – Or Their Mode Of Use – Monotherapy Or Combination?
  • Abstract Number: 1345
    Retinal Vascular Calibre – a Novel Biomarker Of Inflammation and Treatment Response In Rheumatoid Arthritis
  • Abstract Number: 2782
    Retreatment With Rituximab In The Rituximab In ANCA-Associated Vasculitis (RAVE) Trial
  • Abstract Number: 433
    Retrospective Analysis Of Certolizumab Pegol Use During Pregnancy: Update Of Impact On Birth Outcomes
  • Abstract Number: 972
    Retrospective Self-Assessment Of Pre-Course Competency: A Useful Tool For Musculoskeletal Curriculum Assessment In a Multi-Center, Interprofessional Cohort
  • Abstract Number: 444
    Reversibility Of Pharmacodynamic Effects After Short- and Long-Term Treatment With Tofacitinib In Patients With Rheumatoid Arthritis
  • Abstract Number: 1387
    Reversing Vascular Dysfunction In Rheumatoid Arthritis: Peroxisome Proliferator-Activated Receptor Gamma Agonist Therapy Improves Augmentation Index But Not Endothelial Function
  • Abstract Number: 2786
    Review Of The Expert Panel Methodology In The Diagnostic and Classification Criteria For Vasculitis Study: A Pilot Study
  • Abstract Number: 2762
    Rheumatoid and Psoriatic Arthritis Are Not Associated With Higher Risk Of Incident Diabetes Mellitus
  • Abstract Number: 1220
    Rheumatoid Arthritis Characteristics and Fracture Risk: A Population-Based Study
  • Abstract Number: 2308
    Rheumatoid Arthritis Flares: Inflammatory Or Avalanche?
  • Abstract Number: 386
    Rheumatoid Arthritis Is Associated With Systemic Inflammation In Coronary Vessels
  • Abstract Number: 1709
    Rheumatoid Arthritis Patient Cardiovascular Disease Prevention Experiences: Qualitative Analysis and Implications
  • Abstract Number: 181
    Rheumatoid Arthritis Quality Measure Results In a Large Managed Care Population
  • Abstract Number: 1153
    Rheumatoid Arthritis Synovial Fibroblasts Lack Tolerization Of Inflammatory Cytokines and Matrix Degrading Enzymes After Repeated LPS Stimulation
  • Abstract Number: 1653
    Rheumatoid Arthritis Synovial IL-21+CD4+ T Cells Specifically Induce Matrix Metalloproteinase Production By Fibroblast-Like Synoviocytes
  • Abstract Number: 409
    Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lung Inflammation Evaluated With High Resolution Computed Tomography Scan Is Correlated To Rheumatoid Arthritis Disease Activity
  • Abstract Number: 2407
    Rheumatoid Arthritis-Related Autoantibodies In The Lung Evolve Over Time In Subjects At Elevated Risk For Future Rheumatoid Arthritis
  • Abstract Number: 346
    Rheumatoid Arthritis, a More Severe Disease Than Psoriatic Arthritis? A Comparison Of Disease Activity In Patients With Psoriatic Arthritis and Rheumatoid Arthritis From The Swedish Early Psoriatic Arthritis Registry (SwePsA) and The Swedish Rheumatology Registry For Early RA (SRR)
  • Abstract Number: 1844
    Rheumatoid Arthritis, Sjogren’s Syndrome and Systemic Lupus Erythematosus Patients Have a Distinct Spectrum Of Serum Anticytokine Autoantibodies
  • Abstract Number: 122
    Rheumatologists Lack Confidence in Their Knowledge of Cannabinoid Molecules and Use in the Management of Rheumatic Disease Patients: Analysis of a Needs Assessment
  • Abstract Number: 2300
    Rheumatologists Who Are Consistently Using An Objective Outcome Instrument Do Not “Treat To Target” In a Real World Setting
  • Abstract Number: 1919
    Rheumatology-Ophthalmology Collaborative Uveitis Units May Improve The Diagnostic Approach Of This Pathology: Experience From a Uveitis Unit In a Secondary Spanish Hospital
  • Abstract Number: 1180
    Rising Burden Of Gout and Poor Management Of The Disease In The United Kingdom: A Nationwide Population Study
  • Abstract Number: 1216
    Risk Factors Associated With Fracture Occurrence Appear to Differ Between Distal Radius, Clinical Vertebral, and Hip Fractures in Japanese Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study
  • Abstract Number: 2048
    Risk Factors For Glucocorticoids-Induced Diabetes In Patients With Rheumatic Diseases
  • Abstract Number: 91
    Risk Factors For Incident Hyperuricemia During Mid-Adulthood In African American and White Men and Women Enrolled In The Atherosclerosis Risk In Communities Study
  • Abstract Number: 377
    Risk Factors For Stroke In Patients With Rheumatoid Arthritis
  • Abstract Number: 1270
    Risk Factors For The Development Of Avascular Necrosis In Pediatric Systemic Lupus Erythematosus Patients
  • Abstract Number: 806
    Risk Of Cancer Recurrence Or New Tumors In RA Patients With Prior Malignancies Treated With Various Biologic Agents
  • Abstract Number: 332
    Risk Of Cardiovascular Disease Among Patients With Psoriatic Arthritis Compared To Ankylosing Spondylitis (retrospective cohort study)
  • Abstract Number: 1720
    Risk Of Cardiovascular Disease and Use Of Xanthine Oxidase Inhibitors For Gout
  • Abstract Number: 303
    Risk Of Cardiovascular Events In Patients With Psoriatic Arthritis, Psoriasis, and Rheumatoid Arthritis: A General Population-Based Cohort Study
  • Abstract Number: 267
    Risk Of Falls Increases With Additional Symptomatic Osteoarthritic Joints: The Johnston County Osteoarthritis Project
  • Abstract Number: 1039
    Risk Of High-Grade Cervical Dysplasia In Women With Systemic Inflammatory Diseases
  • Abstract Number: 1673
    Risk Of Myocardial Infarction In Patients With Giant Cell Arteritis: A Population-Based Study
  • Abstract Number: 2680
    Risk of Subsequent Infection among Rheumatoid Arthritis  Patients Using Biologics
  • Abstract Number: 361
    Risk Of Venous Thromboembolism and Use Of Disease-Modifying Antirheumatic Drugs For Rheumatoid Arthritis
  • Abstract Number: 2649
    Rituximab For The Treatment Of IgG4-Related Disease: A Prospective Clinical Trial
  • Abstract Number: 1612
    Rituximab For Treatment Of Refractory Auto-Immune Hepatitis
  • Abstract Number: 2164
    Rituximab In The Treatment Of Children With Systemic LUPUS Erythematosus: ONE Year Analysis Of 12 Patients
  • Abstract Number: 2783
    Rituximab Versus Azathioprine For Maintenance In Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis: Follow Up At 39 Months
  • Abstract Number: 1485
    RNA Transcripts From Peripheral Blood Mononuclear Cells As Predictors Of Clinical Responsiveness In Rheumatoid Arthritis Subjects Treated With Abatacept
  • Abstract Number: 1565
    RNA-Sequencing Confirms Clinical Safety Of Herpes Zoster Vaccine
  • Abstract Number: 1489
    RNA-Sequencing Identifies Novel Differentially Expressed Coding and Non-Coding Transcripts In Sjögren’s Syndrome
  • Abstract Number: 2194
    RNA-Sequencing In Peripheral Blood Mononuclear Cells  Identifies Novel Differentially Expressed Coding and Non-Coding Transcripts In Juvenile Idiopathic Arthritis
  • Abstract Number: 922
    Role Of B Cells and/Or Autoantibodies In Pulmonary Manifestations Of Inflammatory Arthritis
  • Abstract Number: 532
    Role Of Baseline C-Reactive Protein In Response To Infliximab Plus Naproxen Vs Naproxen Alone In Patients With Axial Spondyloarthritis
  • Abstract Number: 888
    Role of Calcium/Calmodulin Kinase IV On Podocyte Function in Lupus Nephritis
  • Abstract Number: 916
    Role Of CD20+ B Cells As Antigen-Presenting Cells In Arthritis
  • Abstract Number: 687
    Role Of Class II Human Leukocyte Antigens In The Progression From Early To Definite Systemic Sclerosis
  • Abstract Number: 2487
    Role Of IL-33 In The Development Of Premature Atherosclerosis In Psoriatic Arthritis Patients
  • Abstract Number: 1766
    Role Of IL33 In The Inflammation Of Takayasu Arteritis
  • Abstract Number: 729
    Role Of Innate Immunity In The Pathogenesis Of ANCA-Associated Vasculitis
  • Abstract Number: 2723
    Role Of Interferon-Inducible RNA-Dependent Protein Kinase In The Pathogenesis Of Systemic Lupus Erythematosus
  • Abstract Number: 2188
    Role of Interleukin-1 in Abnormal Monocyte Phenotype in Systemic Onset Juvenile Idiopathic Arthritis
  • Abstract Number: 2081
    Role Of Muscle Persistent CD28null T Cells In Glucocorticoid Therapy Resistance In Myositis Patients
  • Abstract Number: 57
    Role Of Procatabolic Cytokines In Dysregulation Of O-Linked N-Acetylglucosamine Modified Proteins In Human Osteoarthritic Chondrocytes
  • Abstract Number: 564
    Role of TLR3 and dsRNA Hyper-Responsiveness in the Generation of the Lupus-Like Phenotype of New Zealand Black Congenic Mice
  • Abstract Number: 880
    Role Of Urinary Podocyte Number and Urinary Podocalyxin Level As Biomarkers Of Glomerulonephritis In Systemic Lupus Erythematosus and ANCA-Associated Vasculitis
  • Abstract Number: 863
    Romosozumab Administration Is Associated With Significant Improvements In Lumbar Spine and Hip Volumetric Bone Mineral Density and Content Compared With Teriparatide
  • Abstract Number: 119
    Routine Assessment Of Patient Index Data 3 In Fibromyalgia: A Rapid and Reliable Instrument For Evaluating Disease Severity?
  • Abstract Number: 1527
    Routine Assessment Of Patient Index Data 3 Scores Correlate Well With Bath Ankylosing Spondylitis Disease Activity Index In The Assessment Of Disease Activity and Monitoring Progression Of Ankylosing Spondylitis
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences